Recurrence and Tailoring Radiotherapy Following Neoadjuvant Chemotherapy

September 4, 2014
Eleftherios Mamounas, MD, MPH

Eleftherios Mamounas, MD, MPH, discusses locoregional recurrence and tailoring radiotherapy following neoadjuvant chemotherapy.

Clinical Pearls

Eleftherios Mamounas, MD, MPH, medical director, Comprehensive Breast Program, University of Florida Health Cancer Center, discusses locoregional recurrence and tailoring radiotherapy following neoadjuvant chemotherapy.

  • Researchers are trying to understand whether the response and tumor subtype of patients treated with neoadjuvant chemotherapy can help to tailor the use of radiotherapy afterwards.
  • Though the data from this analysis do not provide a definitive answer, they help researchers understand that these patients had low rates of recurrence and tailoring radiotherapy is possible. Trials are in progress to test this concept.

<<<

Back to the 2014 Breast Cancer Symposium conference page